Larvol Delta - PureTech-Initiates-LateStage-Clinical-Study-of-WhollyOwned-Candidate-LYT100-Deupirfenidone-in-IPF-and-Advances-LYT200-AntiGalectin9-mAb

LYT-200 - PureTech

deuterium pirfenidone (LYT-100) - PureTech

https://www.businesswire.com/news/home/20220630005245/en/PureTech-Initiates-Late-Stage-Clinical-Study-of-Wholly-Owned-Candidate-LYT-100-Deupirfenidone-in-IPF-and-Advances-LYT-200-Anti-Galectin-9-mAb

Jun 30, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next